Robert A. Ortenzio - 29 Jun 2023 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Role
EXECUTIVE CHAIRMAN, Director
Signature
/s/ Michael E. Tarvin, Attorney-in-Fact
Issuer symbol
SEM
Transactions as of
29 Jun 2023
Net transactions value
-$3,200,000
Form type
4
Filing time
30 Jun 2023, 17:27:13 UTC
Previous filing
22 Jun 2023
Next filing
11 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEM Common Stock Sale $3,200,000 -100,000 -7.3% $32.00 1,279,000 29 Jun 2023 By the Robert A. Ortenzio Descendants Trust F1, F2
holding SEM Common Stock 6,939,668 29 Jun 2023 Direct
holding SEM Common Stock 3,804,805 29 Jun 2023 By the Rocco A. Ortenzio Separate Exempt Descendants Trust F2
holding SEM Common Stock 280,415 29 Jun 2023 By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio F2
holding SEM Common Stock 280,415 29 Jun 2023 By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio F2
holding SEM Common Stock 280,415 29 Jun 2023 By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on December 9, 2022.
F2 The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.